![Bruno Wohlschlegel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bruno Wohlschlegel served as Chief Executive Officer at APONTIS PHARMA Deutschland GmbH & Co. KG from 2023 to 2025.
Mr. Wohlschlegel served as Chief Executive Officer at APONTIS PHARMA AG from 2023 to 2025.
Former jobs include Chief Executive Officer at APONTIS PHARMA Deutschland GmbH & Co. KG and APONTIS PHARMA AG.
| Sociétés | Poste | Fin |
|---|---|---|
| APONTIS PHARMA AG | Directeur Général | 31/08/2025 |
Apontis Pharma GmbH & Co. KG
 Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Directeur Général | 01/08/2025 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Apontis Pharma GmbH & Co. KG
Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
APONTIS PHARMA AG
 APONTIS PHARMA AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
